Related Experiment Video
Updated: Mar 15, 2026

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions
Published on: May 8, 2017
Prediction of Drug Penetration in Tuberculosis Lesions
Jansy P Sarathy1, Fabio Zuccotto2, Ho Hsinpin1
1Public Health Research Institute Centre, New Jersey Medical School, Rutgers , 225 Warren Street, Newark, New Jersey 07103, United States.
Abstract:
The penetration of antibiotics in necrotic tuberculosis lesions is heterogeneous and drug-specific, but the factors underlying such differential partitioning are unknown. We hypothesized that drug binding to macromolecules in necrotic foci (or caseum) prevents passive drug diffusion through avascular caseum, a critical site of infection. Using a caseum binding assay and MALDI mass spectrometry imaging of tuberculosis drugs, we showed that binding to caseum inversely correlates with passive diffusion into the necrotic core. We developed a high-throughput assay relying on rapid equilibrium dialysis and a caseum surrogate designed to mimic the composition of native caseum. A set of 279 compounds was profiled in this assay to generate a large data set and explore the physicochemical drivers of free diffusion into caseum. Principle component analysis and modeling of the data set delivered an in silico signature predictive of caseum binding, combining 69 molecular descriptors. Among the major positive drivers of binding were high lipophilicity and poor solubility. Determinants of molecular shape such as the number of rings, particularly aromatic rings, number of sp(2) carbon counts, and volume-to-surface ratio negatively correlated with the free fraction, indicating that low-molecular-weight nonflat compounds are more likely to exhibit low caseum binding properties and diffuse effectively through caseum. To provide simple guidance in the property-based design of new compounds, a rule of thumb was derived whereby the sum of the hydrophobicity (clogP) and aromatic ring count is proportional to caseum binding. These tools can be used to ensure desirable lesion partitioning and guide the selection of optimal regimens against tuberculosis.
Insights
Antibiotic penetration into tuberculosis lesions is uneven. Drug binding to lesion material (caseum) hinders diffusion, but molecular properties like shape and lipophilicity can predict better penetration for improved tuberculosis treatment.
Area of Science:
- Pharmacology
- Infectious Diseases
- Medicinal Chemistry
Background:
- Antibiotic penetration into necrotic tuberculosis lesions (caseum) is variable and poorly understood.
- Caseum is a critical site for Mycobacterium tuberculosis infection.
- Factors influencing drug partitioning within caseum are unknown.
Purpose of the Study:
- To investigate the factors governing antibiotic diffusion into necrotic tuberculosis lesions.
- To develop predictive tools for optimizing drug properties for better caseum penetration.
- To identify molecular characteristics that enhance or impede drug diffusion into caseum.
Main Methods:
- Developed a caseum binding assay and a high-throughput assay using rapid equilibrium dialysis with a caseum surrogate.
- Utilized MALDI mass spectrometry imaging to analyze drug distribution in caseum.
- Profiled 279 compounds to identify physicochemical drivers of diffusion.
- Applied principle component analysis and modeling to derive an in silico predictive signature.
Main Results:
- Drug binding to caseum inversely correlated with passive diffusion.
- High lipophilicity and poor solubility were major drivers of caseum binding.
- Molecular shape descriptors (ring count, aromatic rings, sp(2) carbons, volume-to-surface ratio) influenced diffusion.
- An in silico signature combining 69 molecular descriptors predicted caseum binding.
- A simple rule of thumb related hydrophobicity and aromatic ring count to caseum binding.
Conclusions:
- Drug binding to caseum macromolecules limits passive diffusion, impacting tuberculosis treatment efficacy.
- Molecular properties, particularly lipophilicity and shape, are critical determinants of drug penetration into necrotic lesions.
- Developed predictive tools and a rule of thumb to guide the design of new anti-tuberculosis drugs with improved caseum partitioning.
More Related Videos
09:58Spatial Quantification of Drugs in Pulmonary Tuberculosis Lesions by Laser Capture Microdissection Liquid Chromatography Mass Spectrometry LCM-LC/MS
Published on: April 18, 2018
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...